Clinical Trials Browser

Phase I: To Determine the Maximum Tolerated Dose (MTD) × Oxaliplatin × Clear all

NCT01106066 2013-06-14

Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT

Phase 1/2 Terminated

Phase I: To Determine the Maximum Tolerated Dose (MTD)